Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Biology, staging, and treatment of breast cancer during pregnancy: reassessing the evidences.

Peccatori FA, Lambertini M, Scarfone G, Del Pup L, Codacci-Pisanelli G.

Cancer Biol Med. 2018 Feb;15(1):6-13. doi: 10.20892/j.issn.2095-3941.2017.0146.

2.

Whole body MRI for systemic staging of breast cancer in pregnant women.

Peccatori FA, Codacci-Pisanelli G, Del Grande M, Scarfone G, Zugni F, Petralia G.

Breast. 2017 Oct;35:177-181. doi: 10.1016/j.breast.2017.07.014. Epub 2017 Jul 27.

PMID:
28756339
3.

Mechanisms of chemotherapy-induced ovarian damage in breast cancer patients.

Codacci-Pisanelli G, Del Pup L, Del Grande M, Peccatori FA.

Crit Rev Oncol Hematol. 2017 May;113:90-96. doi: 10.1016/j.critrevonc.2017.03.009. Epub 2017 Mar 16. Review.

PMID:
28427528
4.

Letter to the Editor - DTC chemotherapy regimen is associated with higher incidence of premature ovarian failure in women of reproductive age with breast cancer.

Del Pup L, Codacci Pisanelli G, Schettini S, Guido M, Peccatori FA.

Eur Rev Med Pharmacol Sci. 2016 Oct;20(19):3955-3956. No abstract available.

5.

Epigenetic treatment of solid tumours: a review of clinical trials.

Nervi C, De Marinis E, Codacci-Pisanelli G.

Clin Epigenetics. 2015 Dec 10;7:127. doi: 10.1186/s13148-015-0157-2. eCollection 2015. Review.

6.

Medical treatment of early stage and rare histological variants of epithelial ovarian cancer.

Cont NT, Ferrero A, Peccatori FA, D'Alonzo M, Codacci-Pisanelli G, Colombo N, Biglia N.

Ecancermedicalscience. 2015 Oct 22;9:584. doi: 10.3332/ecancer.2015.584. eCollection 2015. Review.

7.

Attitudes on fertility issues in breast cancer patients: an Italian survey.

Biglia N, Torrisi R, D'Alonzo M, Codacci Pisanelli G, Rota S, Peccatori FA.

Gynecol Endocrinol. 2015 Jun;31(6):458-64. doi: 10.3109/09513590.2014.1003293. Epub 2015 May 18.

8.

Surveillance for recurrence of colorectal cancer.

Sinjari M, Zoccoli G, Codacci-Pisanelli G.

JAMA. 2014 May;311(20):2127-8. doi: 10.1001/jama.2014.3398. No abstract available.

PMID:
24867017
9.

Breast cancer risk after exposure to fertility drugs.

Lo Russo G, Spinelli GP, Tomao S, Rossi B, Frati L, Panici PB, Vici P, Codacci Pisanelli G, Tomao F.

Expert Rev Anticancer Ther. 2013 Feb;13(2):149-57. doi: 10.1586/era.12.181. Review.

PMID:
23406556
10.

Improving care and reducing costs in oncology.

Codacci-Pisanelli G.

Ecancermedicalscience. 2013 Dec 3;7:ed31. doi: 10.3332/ecancer.2013.ed31. eCollection 2013. No abstract available.

11.

The AACR 2013 in Washington D.C.

Codacci-Pisanelli G.

Ecancermedicalscience. 2013 May 17;7:ed19. doi: 10.3332/ecancer.2013.ed19. eCollection 2013. No abstract available.

12.

What's wrong with early diagnosis of breast cancer in young women?

Codacci-Pisanelli G.

Ecancermedicalscience. 2013 Mar 12;7:ed17. doi: 10.3332/ecancer.2013.ed17. eCollection 2013. No abstract available.

13.

Chemotherapy, targeted agents, antiemetics and growth-factors in human milk: how should we counsel cancer patients about breastfeeding?

Pistilli B, Bellettini G, Giovannetti E, Codacci-Pisanelli G, Azim HA Jr, Benedetti G, Sarno MA, Peccatori FA.

Cancer Treat Rev. 2013 May;39(3):207-11. doi: 10.1016/j.ctrv.2012.10.002. Epub 2012 Nov 28. Review.

PMID:
23199900
14.

Chemotherapy and target therapy in the management of adult high- grade gliomas.

Spinelli GP, Miele E, Lo Russo G, Miscusi M, Codacci-Pisanelli G, Petrozza V, Papa A, Frati L, Della Rocca C, Gulino A, Tomao S.

Curr Cancer Drug Targets. 2012 Oct;12(8):1016-31. Review.

PMID:
22831277
15.

TFAP2E-DKK4 and chemoresistance in colorectal cancer.

Giovannetti E, Codacci-Pisanelli G, Peters GJ.

N Engl J Med. 2012 Mar 8;366(10):966; author reply 966. doi: 10.1056/NEJMc1201170. No abstract available.

16.

"The only thing I know is that I know nothing": 5-fluorouracil in human milk.

Peccatori FA, Giovannetti E, Pistilli B, Bellettini G, Codacci-Pisanelli G, Losekoot N, Curigliano G, Azim HA Jr, Goldhirsch A, Peters GJ.

Ann Oncol. 2012 Feb;23(2):543-4. doi: 10.1093/annonc/mdr582. No abstract available.

PMID:
22275286
17.

Three cheers for targeted therapy in non-small cell lung cancer... When we hit the target!

Codacci-Pisanelli G, Frati L, Mini E.

J Chemother. 2011 Aug;23(4):245-6. No abstract available.

PMID:
21803707
18.

KRAS genotypes and outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab.

Zaccarelli E, Tomao S, Codacci-Pisanelli G.

JAMA. 2011 Feb 9;305(6):565-6; author reply 566. doi: 10.1001/jama.2011.87. No abstract available.

PMID:
21304079
19.

Preoperative intensified radiochemotherapy for rectal cancer: experience of a single institution.

Dionisi F, Musio D, Raffetto N, Codacci-Pisanelli G, Iannacone E, Caiazzo R, Banelli E.

Int J Colorectal Dis. 2011 Feb;26(2):153-64. doi: 10.1007/s00384-010-1064-9. Epub 2010 Nov 25.

PMID:
21107849
20.

Have we reached a plateau in adjuvant breast cancer therapy?

Codacci-Pisanelli G, Spinelli GP, Peccatori FA.

Lancet. 2009 Oct 24;374(9699):1421. doi: 10.1016/S0140-6736(09)61862-6. No abstract available.

PMID:
19854372
21.

Chemotherapy and immunotherapy in metastatic colorectal cancer.

Frati L, Codacci-Pisanelli G.

N Engl J Med. 2009 May 14;360(20):2134-5; author reply 2135-6. No abstract available.

PMID:
19445031
22.

K-ras mutations and cetuximab in colorectal cancer.

Codacci-Pisanelli G, Spinelli G, Tomao S.

N Engl J Med. 2009 Feb 19;360(8):835; author reply 835-6. No abstract available.

PMID:
19238679
23.

Chemotherapy and radiotherapy for anal canal carcinoma.

Musio D, Codacci-Pisanelli G.

JAMA. 2008 Sep 24;300(12):1410-1; author reply 1411. doi: 10.1001/jama.300.12.1410-c. No abstract available.

PMID:
18812528
24.

Selective protection by uridine of growth inhibition by 5-fluorouracil (5FU) mediated by 5FU incorporation into RNA, but not the thymidylate synthase mediated growth inhibition by 5FU-leucovorin.

Codacci-Pisanelli G, Noordhuis P, van der Wilt CL, Peters GJ.

Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):733-9. doi: 10.1080/15257770802145496.

PMID:
18600533
25.

An acute promyelocytic leukaemia patient with a new atypical promyelocytic leukemia breakpoint.

Cenfra N, De Cave F, Minotti C, Ghia E, Rago A, Codacci Pisanelli G, Diverio D, Cimino G.

Br J Haematol. 2008 Sep;142(5):854-6. doi: 10.1111/j.1365-2141.2008.07253.x. No abstract available.

PMID:
18573113
26.

Effect of epoetin on survival in patients with breast cancer.

Codacci-Pisanelli G, Spinelli GP, Tomao S.

J Clin Oncol. 2008 May 20;26(15):2599; author reply 2599-600. doi: 10.1200/JCO.2008.16.7262. No abstract available.

PMID:
18487580
27.

Pharmacokinetics of bolus 5-fluorouracil: relationship between dose, plasma concentrations, area-under-the-curve and toxicity.

Codacci-Pisanelli G, Pinedo HM, Lankelma J, Van Groeningen CJ, Van Kuilenburg AB, Van Gennip AH, Peters GJ.

J Chemother. 2005 Jun;17(3):315-20.

PMID:
16038526
28.

Quantitative real time PCR of deoxycytidine kinase mRNA by Light Cycler PCR in relation to enzyme activity and gemcitabine sensitivity.

Sigmond J, Kroep JR, Loves W, Codacci-Pisanelli G, Peters GJ.

Cancer Lett. 2004 Sep 30;213(2):173-9.

PMID:
15327832
29.

Intravesical administration of gemcitabine in superficial bladder cancer: a phase I study with pharmacodynamic evaluation.

De Berardinis E, Antonini G, Peters GJ, Loves WJ, Van der Born K, Codacci-Pisanelli G, Di Silverio F.

BJU Int. 2004 Mar;93(4):491-4.

PMID:
15008715
30.

High-dose 5-Fluorouracil with uridine-diphosphoglucose rescue increases thymidylate synthase inhibition but not 5-Fluorouracil incorporation into RNA in murine tumors.

Codacci-Pisanelli G, Van der Wilt CL, Smid K, Noordhuis P, Voorn D, Pinedo HM, Peters GJ.

Oncology. 2002;62(4):363-70.

PMID:
12138245
31.

Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism.

Peters GJ, Backus HH, Freemantle S, van Triest B, Codacci-Pisanelli G, van der Wilt CL, Smid K, Lunec J, Calvert AH, Marsh S, McLeod HL, Bloemena E, Meijer S, Jansen G, van Groeningen CJ, Pinedo HM.

Biochim Biophys Acta. 2002 Jul 18;1587(2-3):194-205. Review.

32.

Activity of ruboxyl, a nitroxyl derivative of daunorubicin, on experimental models of colorectal cancer metastases.

Sirovich I, Konovalova N, Codacci-Pisanelli G, Volkova LM, Giuliani A, Cicconetti F, Seminara P, Mazzocconi G, Franchi F.

Tumour Biol. 1999 Sep-Oct;20(5):270-6.

PMID:
10436420
33.

Modulation of 5-fluorouracil in mice using uridine diphosphoglucose.

Codacci-Pisanelli G, Kralovanszky J, van der Wilt CL, Noordhuis P, Colofiore JR, Martin DS, Franchi F, Peters GJ.

Clin Cancer Res. 1997 Feb;3(2):309-15.

34.

Comparative in vitro and in vivo study of a nitroxyl derivative of 5-fluorouracil (magnizil) on human gastrointestinal tumors.

Seminara P, Bogdanov G, Codacci-Pisanelli G, Leonetti C, Konovalova N, Diatchkovskaya R, Gargano L, Aronne T, Franchi F.

Tumori. 1995 Jul-Aug;81(4):278-82.

PMID:
8540127
35.

Thymidylate synthase and drug resistance.

Peters GJ, van der Wilt CL, van Triest B, Codacci-Pisanelli G, Johnston PG, van Groeningen CJ, Pinedo HM.

Eur J Cancer. 1995 Jul-Aug;31A(7-8):1299-305. Review.

PMID:
7577040
36.

Antitumour activity, toxicity and inhibition of thymidylate synthase of prolonged administration of 5-fluorouracil in mice.

Codacci-Pisanelli G, van der Wilt CL, Pinedo HM, Franchi F, Noordhuis P, Braakhuis BJ, van Laar JA, Peters GJ.

Eur J Cancer. 1995;31A(9):1517-25.

PMID:
7577082
37.

Intermittent continuous infusion of 5-fluorouracil and low dose oral leucovorin in patients with gastrointestinal cancer: relationship between plasma concentrations and clinical parameters.

Poorter RL, Peters GJ, Bakker PJ, Taat CW, Biermans-van Leeuwe DM, Codacci-Pisanelli G, Noordhuis P, Oosting J, Veenhof CH.

Eur J Cancer. 1995;31A(9):1465-70.

PMID:
7577073
38.

5-fluorouracil modulation in the chemotherapy of colorectal cancer.

Codacci-Pisanelli G, Franchi F.

Ital J Gastroenterol. 1994 Sep;26(7):369-76. Review.

PMID:
7529067
39.

Elevated doses of carmustine and mitomycin C, with lonidamine enhancement and autologous bone marrow transplantation in the treatment of advanced colorectal cancer: results from a pilot study.

Franchi F, Seminara P, Codacci Pisanelli G, Guazzugli Bonaiuti VP, Giovagnorio F, Gualdi G.

Eur J Cancer. 1994;30A(10):1420-3.

PMID:
7833095
40.

Comparison of continuous infusions and bolus injections of 5-fluorouracil with or without leucovorin: implications for inhibition of thymidylate synthase.

Peters GJ, Codacci-Pisanelli G, van der Wilt CL, van Laar JA, Smid K, Noordhuis P, Pinedo HM.

Adv Exp Med Biol. 1993;339:9-20; discussion 21. No abstract available.

PMID:
8178733
41.

Is therapy with cytostatics obsolete in hairy-cell leukemia?

Franchi F, Seminara P, Codacci-Pisanelli G, Bianco P.

Int J Clin Lab Res. 1992;22(2):122-3. No abstract available.

PMID:
1504306
42.

Peripheral blood cell repopulation following high-dose cyclophosphamide.

Codacci-Pisanelli G, Franchi F, Afeltra A, Simone F, Bonomo L.

Chemotherapy. 1992;38(4):267-70.

PMID:
1473366
43.

5-Fluorouracil (FU) and mitomycin C (MMC) in the management of colorectal carcinoma. Part II. In vitro activity of the two drugs in short-term tumor cultures.

Franchi F, Barone C, Seminara P, Codacci-Pisanelli G, Codacci-Pisanelli M, Ferri GM, Garufi C, Grieco A, Pagani V.

Med Oncol Tumor Pharmacother. 1991;8(2):75-8.

PMID:
1749303
44.

Discoloration of the nails and early anemia after mitoxantrone, folinic acid and 5-fluorouracil.

Seminara P, Franchi F, Codacci-Pisanelli G, Aronne T, Abdolrahim zadeh S.

Med Oncol Tumor Pharmacother. 1990;7(4):291-2. No abstract available.

PMID:
2283895
45.

Intrarticular methotrexate in the therapy of rheumatoid arthritis.

Franchi F, Seminara P, Codacci-Pisanelli G, Aronne T, Avella A, Bonomo L.

Recenti Prog Med. 1989 May;80(5):261-2.

PMID:
2762663
46.

[Interferon as a sensitizing agent toward chemotherapy in a case of multiple myeloma refractory to treatment].

Seminara P, Codacci-Pisanelli G, Aronne T, Ercoli L, Avella A, Bonomo L.

Recenti Prog Med. 1988 Oct;79(10):415-6. Italian. No abstract available.

PMID:
3247510
47.

Flu-like syndrome due to tritoqualine in cutaneous mastocytosis.

Franchi F, Codacci-Pisanelli G, Aronne T.

Acta Haematol. 1988;79(4):228. No abstract available.

48.

Anthracycline in colorectal carcinoma: an in vitro short-term assay to predict drug sensitivity. Preliminary results.

Seminara P, Franchi F, Mulieri M, D'Amelio R, Codacci Pisanelli G, Aronne T, Manfredi D.

Tumori. 1987 Feb 28;73(1):69-73.

PMID:
3469807
49.

A new anthracycline regimen for prolymphocytic leukemia? Study of a case report with flow cytometric implications.

Franchi F, Seminara P, Codacci-Pisanelli G, Familiari M, Teodori L, Göhde W.

Leuk Res. 1987;11(10):947-9.

PMID:
3479665
50.

Cytosine arabinoside-induced differentiation and killing: unresolved questions.

Franchi F, Seminara P, Codacci-Pisanelli G.

Folia Haematol Int Mag Klin Morphol Blutforsch. 1986;113(3):358-64.

PMID:
2428710

Supplemental Content

Loading ...
Support Center